StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)

Close on Nov 17, 2026Market cap $364.00MP/E –Yield –

CorMedix EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

CorMedix's EV/EBITDA was 0.7× on Nov 11, 2026, against 6.9× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×−7.5
2025Dec 31, 20258.2×–

More CorMedix figures

See a number that looks wrong?